The company will study its vaccine in children, including infants as young as six months and those under 12 in the United States and Canada.
Published: March 16, 2021 at 12:02PM
from NYT Health https://ift.tt/2NlQD0f
The company will study its vaccine in children, including infants as young as six months and those under 12 in the United States and Canada.
Published: March 16, 2021 at 12:02PM
from NYT Health https://ift.tt/2NlQD0f
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Google reCAPTCHA helps protect websites from spam and abuse by verifying user interactions through challenges.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com (opens in a new window)